We Are Tired of Winning Yet? Trump Goes Nuclear on Big Pharma, Brings Home Hostage, and More Victories
Boy, are we tired of winning yet? Are you tired of being right, tired of the art of the deal? It seems like the left is absolutely exhausted from losing. Their cope levels are reaching catastrophic levels.
But for us, the wins just keep coming, and they affect every American. While you may have heard about the China deal, which is great, there are some truly massive moves happening right behind it, especially concerning pharmaceutical prices. We’re seeing things like trade deals, lower costs of goods, energy, and groceries. And now, a direct attack on drug prices.
President Trump has signed an order aimed at slashing some US drug prices by tying them to the significantly lower prices paid abroad. This controversial policy, known as the most favored nation policy, has been revived. The goal is simple: we will pay the lowest price there is in the world. We will get whoever is paying the lowest price – that’s the price we’re going to get. We bigly agree with this.
The fact that these drug companies sell the same drugs for vastly different, cheaper prices in other nations proves they can sell them cheaper here. The problem in America isn’t a free market; it’s government intervention and overregulation, combined with a patent system that grants exclusive rights, allowing companies to charge whatever they want before generics are allowed. While patents help companies recoup R&D, they aren’t playing by the rules. The lack of a single national payer, unlike countries with universal healthcare where the government negotiates, means insurance companies pass costs onto us.
White House officials didn’t specify which medications will be affected, but the order impacts the commercial market, Medicare, and Medicaid. There will be a particular focus on drugs with the largest price disparities and highest expenditures, which could include popular treatments like GLP1s used for weight loss and diabetes. We think they should start with insulin.
Trump himself claimed drug prices could be cut by 59% or more. During a press event, he even suggested they might fall between 59% and 80%, or maybe even 90%. While the actual outcome might be closer to 20% or 30%, like we’ve seen with tariffs, any reduction is a win.
A key part of the order targets nations abroad. The United States will no longer subsidize the healthcare of foreign countries. Trump stated we will no longer tolerate profiteering and price gouging from big pharma. It’s other countries, particularly like those in the brutal European Union, that have forced drug companies to negotiate lower prices, and we should be paying what Europe is paying. The idea is to cut out the middleman and facilitate direct sale of drugs to American citizens at the most favored nation price.
Within 30 days, the Secretary is tasked with setting clear targets for price reductions across all US markets, opening up negotiations between Health and Human Services and the pharmaceutical industry.
Crucially, this is not price control, as the left tries to claim. It’s correcting distortions caused by existing government and regulatory structures.
Beyond drug prices, we’ve seen other major wins in just one week. The last American hostage held by Hamas, Adon Alexander, has been freed. Trump is out there making deals. We’ve also seen a UK trade deal secured, and a China trade deal that acts as a pause and reset. There have been ceasefires in India/Pakistan (though we need to look more into potential radiation fallout there) and with the Houthies.
There’s been media obsession over Trump receiving a jet from Qatar. Honestly, we don’t really care. After living through the corruption of Biden and Hunter, we’ve run out of concern about politicians enriching themselves. Our only real concern is his safety, questioning if a jet comes with strings attached. Optically it looks bad, but ultimately, the focus should be on the wins that affect Americans, like drug prices, not a jet that doesn’t affect us.
The stock market is showing positive signs too. The Dow Jones was up significantly recently, and the Nasdaq has moved past its “Liberation Day” numbers from April and is up over the last month. These are all excellent victories.
We just want to keep winning for the American people. These moves against big pharma, bringing home hostages, securing trade deals – it’s incredible. While the China deal still needs to fully bear out, the direction is clear. Why should Americans pay more than everyone else? We have a million negotiators here, unlike countries that can act as a single payer.
Let them cope. We’ll keep winning.
